VYNE Therapeutics (VYNE) EBT Margin Growth (1y) (2018 - 2026)
VYNE Therapeutics (VYNE) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | 13,290.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,290.00 |
| Jun 30, 2025 | -100,205.00 |
| Mar 31, 2025 | 193,950.00 |
| Dec 31, 2024 | -637,514.00 |
| Sep 30, 2024 | -472,167.00 |
| Jun 30, 2024 | 529,305.00 |
| Mar 31, 2024 | -62,900.00 |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 21,648.00 |
| Jun 30, 2023 | -350,229.00 |
| Mar 31, 2023 | -72,773.00 |
| Dec 31, 2022 | -2.35 Mn |
| Sep 30, 2022 | 519,192.00 |
| Jun 30, 2022 | -291,368.00 |
| Mar 31, 2022 | -15,557.00 |
| Dec 31, 2021 | -268,992.00 |
| Sep 30, 2021 | -997,785.00 |
| Jun 30, 2021 | -218,724.00 |
| Mar 31, 2021 | -242,967.00 |
| Dec 31, 2020 | 2.75 Mn |